| HAI | Healthcare-associated infections |
| AMR | Antimicrobial resistance |
| AU | Antibiotic use |
| HA-CDI | Healthcare-associated Clostridioides difficile infection |
| ICU | Intensive care units |
| ASP | Antibiotic stewardship program |
| ID | Incidence density |
| BSI | Bloodstream infection |
| CVC | Central venous catheter |
| UTI | Urinary tract infection |
| UC | Urinary catheter |
| WHO | World Health Organization |
| AwaRe | “Access,” “Watch,” or “Reserve” |
| DOT | days of therapy’ |
| ATC | Anatomical therapeutic chemical |
| RSD | Serbian dinars |
| MMA | Military Medical Academy |
| MDR | Multidrug-resistant |
| ECDC | European Centre for Disease Prevention and Control |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| VRE | Vancomycin-resistant Enterococcus spp. |
| EU | European union |
| EEA | European Economic Area |
| UK | United Kingdom |
| MIC | Minimum inhibitory concentrations |
| OXA | Oxacillin |
| GLY | Glycopeptides |
| CTX | Cefotaxime |
| CRO | Ceftriaxone |
| CAZ | Ceftazidime |
| CAR | Carbapenems |
| IPM | Imipenem |
| MEM | Meropenem |
| ETP | Ertapenem |
| GDH | Glutamate dehydrogenase |
| SD | Standard deviation |